CIK 0001372514
- Non-accelerated filer
- Smaller reporting company
KIORA PHARMACEUTICALS INC
Sign in to watch- Tickers
- KPRX KPHMW
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 980443284
- Phone
- +1 858-224-9600
- Business address
- 169 SAXONY RD., SUITE 212, ENCINITAS, CA, 92024
- Former names
- EYEGATE PHARMACEUTICALS INC
Securities
- KPRX Common Stock Nasdaq
- KPHMW Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 73 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-03-29 | ARMISTICE CAPITAL, LLC Director | Purchase | +0 | 17,812,500 | ||
| 2019-03-28 | ARMISTICE CAPITAL, LLC Director | Purchase | +130,811 | $0.31 | $41K | 17,514,311 |
| 2019-03-28 | ARMISTICE CAPITAL, LLC Director | Purchase | +0 | 17,514,311 | ||
| 2019-03-27 | ARMISTICE CAPITAL, LLC Director | Purchase | +120,647 | $0.35 | $42K | 17,383,500 |
| 2019-03-27 | ARMISTICE CAPITAL, LLC Director | Purchase | +0 | 17,383,500 | ||
| 2019-02-01 | CHANEY PAUL G Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2019-02-01 | Greenleaf Peter Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2019-02-01 | GOLDBERG MORTON Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2019-02-01 | HANCOCK THOMAS Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2019-02-01 | MALFROY-CAMINE BERNARD Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2019-02-01 | TYLE PRAVEEN Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2019-02-01 | FROM STEPHEN President and CEO | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2019-02-01 | Wirostko Barbara Chief Medical Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2019-02-01 | MANZO MICHAEL P. Vice President of Engineering | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2019-02-01 | Mann Brenda VP of Research & Development | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2019-02-01 | Romano Sarah Chief Financial Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2018-12-11 | ARMISTICE CAPITAL, LLC Director | Purchase | +6,800 | $0.42 | $3K | 17,238,700 |
| 2018-12-11 | ARMISTICE CAPITAL, LLC Director | Purchase | +0 | 17,238,700 | ||
| 2018-12-11 | ARMISTICE CAPITAL, LLC Director | Purchase | +0 | 17,238,700 | ||
| 2018-12-11 | ARMISTICE CAPITAL, LLC Director | Purchase | +24,153 | $0.41 | $10K | 17,262,853 |
Page 15 of 24 · 468 trades